SomnoMed Limited (ASX:SOM)

SomnoMed Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 24, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	144	140	55	79	100	183
Market Cap Growth	-1.17%	157.43%	-30.96%	-21.07%	-45.25%	84.17%
Enterprise Value	135	128	60	85	91	167
Last Close Price	0.66	0.65	0.25	0.71	0.90	1.64
Forward PE	49.62	108.33	-	85.27	175.36	62.78
PS Ratio	1.29	1.26	0.60	0.95	1.38	2.92
PB Ratio	3.11	3.03	1.21	3.53	3.60	5.69
P/TBV Ratio	3.82	3.72	1.49	6.03	5.28	7.37
P/FCF Ratio	26.89	26.20	-	-	117.89	331.46
P/OCF Ratio	18.52	18.05	-	-	53.91	67.60
PEG Ratio	1.24	-	-	-	-	-
EV/Sales Ratio	1.21	1.15	0.66	1.02	1.25	2.67
EV/EBITDA Ratio	31.79	80.76	-	-	-	266.60
EV/FCF Ratio	25.16	23.85	-	-	106.83	303.51
Debt / Equity Ratio	0.17	0.17	0.15	1.05	0.43	0.28
Debt / EBITDA Ratio	1.89	1.89	-	63.95	-	3.66
Debt / FCF Ratio	1.50	1.50	-	-	14.14	16.14
Net Debt / Equity Ratio	-0.20	-0.20	-0.21	0.52	-0.13	-0.38
Net Debt / EBITDA Ratio	-5.85	-5.85	1.46	-5.83	1.35	-19.42
Net Debt / FCF Ratio	-1.73	-1.73	1.27	-1.65	-4.28	-22.11
Asset Turnover	1.48	1.48	1.39	1.39	1.27	1.06
Inventory Turnover	6.53	6.53	7.03	8.82	10.45	10.92
Quick Ratio	1.10	1.10	1.23	1.14	1.05	1.81
Current Ratio	1.51	1.51	1.76	1.50	1.27	2.11
Return on Equity (ROE)	-7.56%	-7.56%	-36.31%	-31.35%	-14.77%	-3.28%
Return on Assets (ROA)	-0.26%	-0.26%	-7.87%	-3.74%	-4.52%	-0.91%
Return on Invested Capital (ROIC)	-0.84%	-0.86%	-23.96%	-12.41%	-18.73%	-4.37%
Return on Capital Employed (ROCE)	-0.60%	-0.60%	-16.70%	-8.20%	-12.00%	-2.10%
Earnings Yield	-2.40%	-2.46%	-22.43%	-10.12%	-4.43%	-0.65%
FCF Yield	3.72%	3.82%	-13.60%	-8.88%	0.85%	0.30%
Buyback Yield / Dilution	-75.54%	-75.54%	-53.66%	-0.01%	-0.16%	-24.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.